12:00 AM
 | 
Dec 10, 2012
 |  BC Week In Review  |  Clinical News  |  Clinical Results

VAC-3S: Interim Phase I/IIa data

Interim data from a double-blind, placebo-controlled, French Phase I/IIa trial in 24 HIV-infected patients receiving antiretroviral therapy showed that 3 injections of VAC-3S...

Read the full 95 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >